Champions Oncology (CSBR) Cash from Operations Growth (3y) (2013 - 2026)
Champions Oncology (CSBR) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
37.40% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
16.64% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Champions Oncology |
82.77 Mn |
75.76 Mn |
13.89 Mn |
-41.80% |
| Date | Value |
|---|
| Jan 31, 2026 |
-41.80% |
| Oct 31, 2025 |
-36.23% |
| Jul 31, 2025 |
71.87% |
| Apr 30, 2025 |
105.10% |
| Jan 31, 2025 |
-51.36% |
| Oct 31, 2024 |
-30.66% |
| Jul 31, 2024 |
12.92% |
| Apr 30, 2024 |
2.84% |
| Jan 31, 2024 |
-106.51% |
| Oct 31, 2023 |
-12.49% |
| Jul 31, 2023 |
-77.39% |
| Apr 30, 2023 |
-31.46% |
| Jan 31, 2023 |
77.98% |
| Oct 31, 2022 |
108.99% |
| Jul 31, 2022 |
11.26% |
| Apr 30, 2022 |
46.73% |
| Jan 31, 2022 |
52.09% |
| Oct 31, 2021 |
167.72% |
| Jul 31, 2021 |
-13.69% |
| Apr 30, 2021 |
-505.50% |
